These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8838776)

  • 21. Distribution of odds ratio in 2 × 2 contingency table: adjustment for correlation.
    Biswas A; Hwang JS
    J Biopharm Stat; 2011 Jan; 21(1):136-50. PubMed ID: 21191860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.
    Walters SJ
    Health Qual Life Outcomes; 2004 May; 2():26. PubMed ID: 15161494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
    Basak GK; Biswas A; Volkov S
    J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-stage designs for phase II cancer trials with ordinal responses.
    Stallard N; Cockey L
    Contemp Clin Trials; 2008 Nov; 29(6):896-904. PubMed ID: 18703164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantile-function based null distribution in resampling based multiple testing.
    van der Laan MJ; Hubbard AE
    Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonparametric smoothing method for assessing GEE models with longitudinal binary data.
    Lin KC; Chen YJ; Shyr Y
    Stat Med; 2008 Sep; 27(22):4428-39. PubMed ID: 18613210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.
    Sweeting MJ; Sutton AJ; Lambert PC
    Stat Med; 2004 May; 23(9):1351-75. PubMed ID: 15116347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal design for dose response using beta distributed responses.
    Wu Y; Fedorov VV; Propert KJ
    J Biopharm Stat; 2005; 15(5):753-71. PubMed ID: 16078383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of bioequivalence using a multiplicative model.
    Chow SC; Peace KE; Shao J
    J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nominal analysis of "variance".
    Weiss DJ
    Behav Res Methods; 2009 Aug; 41(3):901-8. PubMed ID: 19587207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy evaluation for monotherapies in two-by-two factorial trials.
    Hung HM; Chi GY; O'Neill RT
    Biometrics; 1995 Dec; 51(4):1483-93. PubMed ID: 8589235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of two methods for adaptive interim analyses in clinical trials.
    Wassmer G
    Biometrics; 1998 Jun; 54(2):696-705. PubMed ID: 9629649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A robust approach for analyzing unbalanced factorial designs with fixed levels.
    Vallejo G; Ato M; Fernández MP
    Behav Res Methods; 2010 May; 42(2):607-17. PubMed ID: 20479192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of ordinal outcomes using individual patient data.
    Whitehead A; Omar RZ; Higgins JP; Savaluny E; Turner RM; Thompson SG
    Stat Med; 2001 Aug; 20(15):2243-60. PubMed ID: 11468762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.